AlzChem Group AG
XETRA:ACT
Balance Sheet
Balance Sheet Decomposition
AlzChem Group AG
AlzChem Group AG
Balance Sheet
AlzChem Group AG
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
13
|
9
|
17
|
8
|
9
|
12
|
62
|
72
|
|
| Cash |
13
|
9
|
17
|
8
|
9
|
12
|
62
|
72
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
5
|
0
|
0
|
0
|
|
| Total Receivables |
42
|
40
|
39
|
50
|
70
|
89
|
91
|
100
|
|
| Accounts Receivables |
34
|
33
|
33
|
41
|
56
|
75
|
79
|
73
|
|
| Other Receivables |
8
|
7
|
6
|
9
|
15
|
14
|
12
|
26
|
|
| Inventory |
79
|
75
|
67
|
87
|
122
|
107
|
101
|
116
|
|
| Other Current Assets |
9
|
7
|
9
|
8
|
7
|
8
|
8
|
9
|
|
| Total Current Assets |
143
|
131
|
133
|
153
|
215
|
217
|
262
|
297
|
|
| PP&E Net |
144
|
176
|
184
|
187
|
188
|
182
|
197
|
280
|
|
| PP&E Gross |
144
|
176
|
184
|
187
|
188
|
182
|
197
|
280
|
|
| Accumulated Depreciation |
154
|
170
|
188
|
208
|
228
|
248
|
266
|
287
|
|
| Intangible Assets |
1
|
2
|
2
|
2
|
3
|
4
|
4
|
4
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
21
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
26
|
35
|
36
|
36
|
17
|
22
|
21
|
17
|
|
| Total Assets |
314
N/A
|
343
+9%
|
354
+3%
|
378
+7%
|
423
+12%
|
425
+0%
|
484
+14%
|
618
+28%
|
|
| Liabilities | |||||||||
| Accounts Payable |
31
|
24
|
21
|
33
|
37
|
32
|
37
|
52
|
|
| Accrued Liabilities |
20
|
18
|
20
|
23
|
21
|
26
|
35
|
31
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
25
|
14
|
14
|
12
|
68
|
10
|
9
|
8
|
|
| Other Current Liabilities |
5
|
5
|
4
|
8
|
5
|
15
|
24
|
28
|
|
| Total Current Liabilities |
81
|
61
|
60
|
76
|
132
|
83
|
105
|
119
|
|
| Long-Term Debt |
33
|
59
|
55
|
43
|
32
|
52
|
43
|
36
|
|
| Deferred Income Tax |
2
|
5
|
5
|
4
|
5
|
6
|
8
|
9
|
|
| Minority Interest |
1
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
|
| Other Liabilities |
129
|
158
|
166
|
165
|
107
|
120
|
120
|
196
|
|
| Total Liabilities |
247
N/A
|
283
+15%
|
287
+2%
|
290
+1%
|
279
-4%
|
263
-6%
|
278
+6%
|
361
+30%
|
|
| Equity | |||||||||
| Common Stock |
102
|
102
|
102
|
102
|
102
|
102
|
102
|
102
|
|
| Retained Earnings |
28
|
19
|
7
|
13
|
34
|
57
|
98
|
146
|
|
| Additional Paid In Capital |
25
|
25
|
25
|
25
|
25
|
25
|
25
|
25
|
|
| Treasury Stock |
0
|
0
|
0
|
1
|
1
|
0
|
2
|
4
|
|
| Other Equity |
32
|
48
|
53
|
51
|
15
|
22
|
18
|
12
|
|
| Total Equity |
67
N/A
|
60
-11%
|
67
+12%
|
88
+31%
|
144
+64%
|
162
+12%
|
206
+27%
|
256
+25%
|
|
| Total Liabilities & Equity |
314
N/A
|
343
+9%
|
354
+3%
|
378
+7%
|
423
+12%
|
425
+0%
|
484
+14%
|
618
+28%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
10
|
10
|
10
|
10
|
10
|
10
|
10
|
10
|
|